{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:27:02Z","timestamp":1793687222079,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11060-022-04225-y","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:03:15Z","timestamp":1673499795000},"page":"23-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis"],"prefix":"10.1007","volume":"161","author":[{"given":"Zachary S.","family":"Mayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Halima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Broughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Smile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"4225_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48","journal-title":"Radiat Oncol"},{"issue":"10","key":"4225_CR2","doi-asserted-by":"publisher","first-page":"e1392","DOI":"10.1212\/WNL.0000000000010190","volume":"95","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang X, Wang X et al (2020) A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis. Neurology 95(10):e1392\u2013e1403","journal-title":"Neurology"},{"issue":"3","key":"4225_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11910-012-0258-7","volume":"12","author":"J Fink","year":"2012","unstructured":"Fink J, Born D, Chamberlain MC (2012) Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors. Curr Neurol Neurosci Rep 12(3):276\u2013285","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"4225_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","volume":"65","author":"JD Ruben","year":"2006","unstructured":"Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65(2):499\u2013508","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4225_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0360-3016(81)90443-0","volume":"7","author":"JE Marks","year":"1981","unstructured":"Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7(2):243\u2013252","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4225_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0360-3016(95)02106-X","volume":"34","author":"E Shaw","year":"1996","unstructured":"Shaw E, Scott C, Souhami L et al (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90\u201305). Int J Radiat Oncol Biol Phys 34(3):647\u2013654","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4225_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JG et al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373\u2013386","journal-title":"J Neurosurg"},{"issue":"1","key":"4225_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijrobp.2014.09.004","volume":"91","author":"JP Kirkpatrick","year":"2015","unstructured":"Kirkpatrick JP, Wang Z, Sampson JH et al (2015) Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. Int J Radiat Oncol Biol Phys 91(1):100\u2013108","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4225_CR9","first-page":"1","volume":"18","author":"A Juloori","year":"2019","unstructured":"Juloori A, Miller JA, Parsai S et al (2019) Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. J Neurosurg 18:1\u20139","journal-title":"J Neurosurg"},{"issue":"6","key":"4225_CR10","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1007\/s00330-020-07514-0","volume":"31","author":"PH Kim","year":"2021","unstructured":"Kim PH, Suh CH, Kim HS et al (2021) Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. Eur Radiol 31(6):4114\u20134129","journal-title":"Eur Radiol"},{"issue":"8","key":"4225_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","volume":"4","author":"AM Martin","year":"2018","unstructured":"Martin AM, Cagney DN, Catalano PJ et al (2018) Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. JAMA Oncol 4(8):1123\u20131124","journal-title":"JAMA Oncol"},{"issue":"4","key":"4225_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00234-020-02621-7","volume":"63","author":"CM Carr","year":"2021","unstructured":"Carr CM, Benson JC, DeLone DR et al (2021) Intracranial long-term complications of radiation therapy: an image-based review. Neuroradiology 63(4):471\u2013482","journal-title":"Neuroradiology"},{"issue":"5","key":"4225_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1148\/rg.325125002","volume":"32","author":"R Shah","year":"2012","unstructured":"Shah R, Vattoth S, Jacob R et al (2012) Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics 32(5):1343\u20131359","journal-title":"Radiographics"},{"issue":"5","key":"4225_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1227\/01.NEU.0000333263.31870.31","volume":"63","author":"IM Dequesada","year":"2008","unstructured":"Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63(5):898\u2013903","journal-title":"Neurosurgery"},{"issue":"1","key":"4225_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-012-0881-9","volume":"109","author":"AL Stockham","year":"2012","unstructured":"Stockham AL, Tievsky AL, Koyfman SA et al (2012) Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 109(1):149\u2013158","journal-title":"J Neurooncol"},{"issue":"3","key":"4225_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1227\/01.NEU.0000360391.35749.A5","volume":"66","author":"H Kano","year":"2010","unstructured":"Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1\/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66(3):486\u2013491","journal-title":"Neurosurgery"},{"issue":"4","key":"4225_CR17","first-page":"586","volume":"19","author":"S Wagner","year":"2017","unstructured":"Wagner S, Lanfermann H, Eichner G, Gufler H (2017) Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI. Neuro Oncol 19(4):586\u2013594","journal-title":"Neuro Oncol"},{"issue":"3","key":"4225_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00330-012-2638-4","volume":"23","author":"J Cha","year":"2013","unstructured":"Cha J, Kim ST, Kim HJ et al (2013) Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression. Eur Radiol 23(3):879\u2013886","journal-title":"Eur Radiol"},{"issue":"1","key":"4225_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-009-0106-z","volume":"99","author":"K Mitsuya","year":"2010","unstructured":"Mitsuya K, Nakasu Y, Horiguchi S et al (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99(1):81\u201388","journal-title":"J Neurooncol"},{"issue":"3","key":"4225_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3174\/ajnr.A1377","volume":"30","author":"LS Hu","year":"2009","unstructured":"Hu LS, Baxter LC, Smith KA et al (2009) Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 30(3):552\u2013558","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"4225_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3174\/ajnr.A1362","volume":"30","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30(2):367\u2013372","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"4225_CR22","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3174\/ajnr.A3995","volume":"35","author":"DY Kim","year":"2014","unstructured":"Kim DY, Kim HS, Goh MJ, Choi CG, Kim SJ (2014) Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience. AJNR Am J Neuroradiol 35(11):2082\u20132090","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"4225_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/CCO.0000000000000793","volume":"33","author":"L Nichelli","year":"2021","unstructured":"Nichelli L, Casagranda S (2021) Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis. Curr Opin Oncol 33(6):597\u2013607","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"4225_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1055\/s-2005-870952","volume":"48","author":"M Chernov","year":"2005","unstructured":"Chernov M, Hayashi M, Izawa M et al (2005) Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. Minim Invasive Neurosurg 48(4):228\u2013234","journal-title":"Minim Invasive Neurosurg"},{"issue":"3","key":"4225_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2176\/nmc.37.250","volume":"37","author":"K Kamada","year":"1997","unstructured":"Kamada K, Houkin K, Abe H, Sawamura Y, Kashiwaba T (1997) Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy. Neurol Med Chir (Tokyo) 37(3):250\u2013256","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4225_CR26","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1016\/j.wneu.2021.05.064","volume":"151","author":"S Travers","year":"2021","unstructured":"Travers S, Joshi K, Miller DC et al (2021) Reliability of magnetic resonance spectroscopy and positron emission tomography computed tomography in differentiating metastatic brain tumor recurrence from radiation necrosis. World Neurosurg 151:e1059\u2013e1068","journal-title":"World Neurosurg"},{"key":"4225_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3171\/sup.2005.102.s_supplement.0266","volume":"102 Suppl","author":"T Serizawa","year":"2005","unstructured":"Serizawa T, Saeki N, Higuchi Y et al (2005) Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 102 Suppl:266\u2013271","journal-title":"J Neurosurg"},{"issue":"12","key":"4225_CR28","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.3174\/ajnr.A4475","volume":"36","author":"G Lai","year":"2015","unstructured":"Lai G, Mahadevan A, Hackney D et al (2015) Diagnostic accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery. AJNR Am J Neuroradiol 36(12):2250\u20132255","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"4225_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-019-1228-x","volume":"14","author":"M Furuse","year":"2019","unstructured":"Furuse M, Nonoguchi N, Yamada K et al (2019) Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review. Radiat Oncol 14(1):28","journal-title":"Radiat Oncol"},{"issue":"5","key":"4225_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/neuonc\/noz003","volume":"21","author":"N Galldiks","year":"2019","unstructured":"Galldiks N, Langen KJ, Albert NL et al (2019) PET imaging in patients with brain metastasis-report of the RANO\/PET group. Neuro Oncol 21(5):585\u2013595","journal-title":"Neuro Oncol"},{"issue":"3","key":"4225_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/ijc.1016","volume":"96","author":"ST Chao","year":"2001","unstructured":"Chao ST, Suh JH, Raja S, Lee SY, Barnett G (2001) The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96(3):191\u2013197","journal-title":"Int J Cancer"},{"issue":"2","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1148\/radiographics.12.2.1561416","volume":"12","author":"EE Kim","year":"1992","unstructured":"Kim EE, Chung SK, Haynie TP et al (1992) Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12(2):269\u2013279","journal-title":"Radiographics"},{"issue":"3","key":"4225_CR33","first-page":"407","volume":"19","author":"PE Ricci","year":"1998","unstructured":"Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19(3):407\u2013413","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1\u20134","key":"4225_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000029743","volume":"73","author":"TP Thompson","year":"1999","unstructured":"Thompson TP, Lunsford LD, Kondziolka D (1999) Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg 73(1\u20134):9\u201314","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"4225_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11060-010-0365-8","volume":"103","author":"LL Horky","year":"2011","unstructured":"Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH (2011) Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol 103(1):137\u2013146","journal-title":"J Neurooncol"},{"issue":"6","key":"4225_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/neuonc\/nov301","volume":"18","author":"V Hatzoglou","year":"2016","unstructured":"Hatzoglou V, Yang TJ, Omuro A et al (2016) A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro Oncol 18(6):873\u2013880","journal-title":"Neuro Oncol"},{"issue":"2","key":"4225_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3174\/ajnr.A5472","volume":"39","author":"H Li","year":"2018","unstructured":"Li H, Deng L, Bai HX et al (2018) Diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiotherapy: a systematic review and meta-analysis. AJNR Am J Neuroradiol 39(2):280\u2013288","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"4225_CR38","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y et al (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49(5):694\u2013699","journal-title":"J Nucl Med"},{"issue":"5","key":"4225_CR39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3171\/jns.2003.98.5.1056","volume":"98","author":"N Tsuyuguchi","year":"2003","unstructured":"Tsuyuguchi N, Sunada I, Iwai Y et al (2003) Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98(5):1056\u20131064","journal-title":"J Neurosurg"},{"issue":"7","key":"4225_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132515","volume":"10","author":"R Minamimoto","year":"2015","unstructured":"Minamimoto R, Saginoya T, Kondo C et al (2015) Differentiation of brain tumor recurrence from post-radiotherapy necrosis with 11C-methionine PET: visual assessment versus quantitative assessment. PLoS One 10(7):e0132515","journal-title":"PLoS One"},{"issue":"1","key":"4225_CR41","doi-asserted-by":"publisher","first-page":"15666","DOI":"10.1038\/s41598-019-52279-2","volume":"9","author":"M Hotta","year":"2019","unstructured":"Hotta M, Minamimoto R, Miwa K (2019) 11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier. Sci Rep 9(1):15666","journal-title":"Sci Rep"},{"issue":"1","key":"4225_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12885-017-3702-x","volume":"17","author":"S Yomo","year":"2017","unstructured":"Yomo S, Oguchi K (2017) Prospective study of (11)C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment. BMC Cancer 17(1):713","journal-title":"BMC Cancer"},{"issue":"5","key":"4225_CR43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3174\/ajnr.A3324","volume":"34","author":"T Nihashi","year":"2013","unstructured":"Nihashi T, Dahabreh IJ, Terasawa T (2013) Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. AJNR Am J Neuroradiol 34(5):944\u2013950","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"4225_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00259-018-4240-8","volume":"46","author":"O Humbert","year":"2019","unstructured":"Humbert O, Bourg V, Mondot L et al (2019) (18)F-DOPA PET\/CT in brain tumors: impact on multidisciplinary brain tumor board decisions. Eur J Nucl Med Mol Imaging 46(3):558\u2013568","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"4225_CR45","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S et al (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47(6):904\u2013911","journal-title":"J Nucl Med"},{"issue":"1","key":"4225_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00259-014-2886-4","volume":"42","author":"F Cicone","year":"2015","unstructured":"Cicone F, Minniti G, Romano A et al (2015) Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging 42(1):103\u2013111","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"4225_CR47","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/neuonc\/noaa239","volume":"23","author":"F Cicone","year":"2021","unstructured":"Cicone F, Carideo L, Scaringi C et al (2021) Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET. Neuro Oncol 23(6):1024\u20131034","journal-title":"Neuro Oncol"},{"issue":"2","key":"4225_CR48","first-page":"281","volume":"19","author":"G Ceccon","year":"2017","unstructured":"Ceccon G, Lohmann P, Stoffels G et al (2017) Dynamic O-(2\u201318F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy. Neuro Oncol 19(2):281\u2013288","journal-title":"Neuro Oncol"},{"issue":"9","key":"4225_CR49","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2967\/jnumed.112.103325","volume":"53","author":"N Galldiks","year":"2012","unstructured":"Galldiks N, Stoffels G, Filss CP et al (2012) Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 53(9):1367\u20131374","journal-title":"J Nucl Med"},{"issue":"1","key":"4225_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13014-016-0713-8","volume":"11","author":"A Romagna","year":"2016","unstructured":"Romagna A, Unterrainer M, Schmid-Tannwald C et al (2016) Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties? Radiat Oncol 11(1):139","journal-title":"Radiat Oncol"},{"issue":"1","key":"4225_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13550-020-00739-6","volume":"10","author":"EE Parent","year":"2020","unstructured":"Parent EE, Patel D, Nye JA et al (2020) [(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis. EJNMMI Res 10(1):148","journal-title":"EJNMMI Res"},{"issue":"3","key":"4225_CR52","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.ijrobp.2021.07.089","volume":"111","author":"M Tom","year":"2021","unstructured":"Tom M, DiFilippo F, Smile T et al (2021) 18F-Fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery: results of a prospective pilot study. Int J Radiat Oncol Biol Phys 111(3):S27","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4225_CR53","unstructured":"Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (REVELATE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04410133. Accessed May 05, 2022."},{"issue":"1","key":"4225_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101275","volume":"15","author":"V Salvestrini","year":"2022","unstructured":"Salvestrini V, Greco C, Guerini AE et al (2022) The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: a critical review by the young group of the Italian association of radiotherapy and clinical oncology (yAIRO). Transl Oncol 15(1):101275","journal-title":"Transl Oncol"},{"issue":"6","key":"4225_CR55","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00330-017-5154-8","volume":"28","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yang J, Ho A et al (2018) A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol 28(6):2255\u20132263","journal-title":"Eur Radiol"},{"issue":"5","key":"4225_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1667\/RR15517.1","volume":"193","author":"L Hettal","year":"2020","unstructured":"Hettal L, Stefani A, Salleron J et al (2020) Radiomics method for the differential diagnosis of radionecrosis versus progression after fractionated stereotactic body radiotherapy for brain oligometastasis. Radiat Res 193(5):471\u2013480","journal-title":"Radiat Res"},{"issue":"1","key":"4225_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-021-03802-x","volume":"154","author":"P Palmisciano","year":"2021","unstructured":"Palmisciano P, Haider AS, Nwagwu CD et al (2021) Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis. J Neurooncol 154(1):13\u201323","journal-title":"J Neurooncol"},{"issue":"6","key":"4225_CR58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1227\/neu.0000000000001922","volume":"90","author":"EW Sankey","year":"2022","unstructured":"Sankey EW, Grabowski MM, Srinivasan ES et al (2022) Time to steroid independence after laser interstitial thermal therapy vs medical management for treatment of biopsy-proven radiation necrosis secondary to stereotactic radiosurgery for brain metastasis. Neurosurgery 90(6):684\u2013690","journal-title":"Neurosurgery"},{"issue":"3","key":"4225_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2013.05.015","volume":"87","author":"ST Chao","year":"2013","unstructured":"Chao ST, Ahluwalia MS, Barnett GH et al (2013) Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys 87(3):449\u2013457","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04225-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T16:03:39Z","timestamp":1675267419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04225-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04225-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samuel Tay Chao (Research support from Blue Earth Diagnostics and Honorarium from Varian Medical Systems). John H. Suh (Scientific advisory board of Philips, NovoCure, and Neutron Therapeutics). Gene H. Barnett (Speaker for Elekta AB, Consultant for Monteris Medical, Inc.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article and no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}